{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:49:11Z","timestamp":1790383751488,"version":"4.1.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1097\/prs.0000000000000015","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T21:05:56Z","timestamp":1396040756000},"page":"543e-551e","source":"Crossref","is-referenced-by-count":33,"title":["Characterization, Prophylaxis, and Treatment of Infectious Complications in Craniomaxillofacial and Upper Extremity Allotransplantation"],"prefix":"10.1097","volume":"133","author":[{"given":"Justin M.","family":"Broyles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alrakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Ensor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saami","family":"Khalifian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille N.","family":"Kotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin K.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Brandacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. P. Andrew","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad R.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20230430","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0140-6736(99)02062-0","article-title":"Human hand allograft: Report on first 6 months.","volume":"353","author":"Dubernard","year":"1999","journal-title":"Lancet"},{"key":"R2-20-20230430","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/TP.0b013e3181ff1472","article-title":"The International Registry on Hand and Composite Tissue Transplantation.","volume":"90","author":"Petruzzo","year":"2010","journal-title":"Transplantation"},{"key":"R3-20-20230430","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1432-2277.2011.01261.x","article-title":"Achievements and challenges in composite tissue allotransplantation.","volume":"24","author":"Schneeberger","year":"2011","journal-title":"Transpl Int"},{"key":"R5-20-20230430","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00006534-199103000-00001","article-title":"Relative antigenicity of components of a vascularized limb allograft.","volume":"87","author":"Lee","year":"1991","journal-title":"Plast Reconstr Surg"},{"key":"R6-20-20230430","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/01.TP.0000113806.52063.42","article-title":"Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine.","volume":"77","author":"Hettiaratchy","year":"2004","journal-title":"Transplantation"},{"key":"R7-20-20230430","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00007890-200301150-00005","article-title":"Split tolerance to a composite tissue allograft in a swine model.","volume":"75","author":"Mathes","year":"2003","journal-title":"Transplantation"},{"key":"R8-20-20230430","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/01.sap.0000182651.68061.5a","article-title":"Combined treatment with CD40 costimulation blockade, T-cell depletion, low-dose irradiation, and donor bone marrow transfusion in limb allograft survival.","volume":"55","author":"Tung","year":"2005","journal-title":"Ann Plast Surg"},{"key":"R9-20-20230430","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1016\/j.transproceed.2010.09.020","article-title":"Immunologic aspects and rejection in solid organ versus reconstructive transplantation.","volume":"42","author":"Hautz","year":"2010","journal-title":"Transplant Proc"},{"key":"R11-20-20230430","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0002-9343(81)90780-4","article-title":"Infection in the renal transplant recipient.","volume":"70","author":"Rubin","year":"1981","journal-title":"Am J Med"},{"key":"R12-20-20230430","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","article-title":"Infection in organ-transplant recipients.","volume":"338","author":"Fishman","year":"1998","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R14-20-20230430","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/320897","article-title":"Epidemiology of infections after solid-organ transplantation.","volume":"33","author":"Snydman","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R15-20-20230430","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1600-6143.2006.01694.x","article-title":"Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: Data from the RESITRA study group.","volume":"7","author":"San Juan","year":"2007","journal-title":"Am J Transplant"},{"key":"R16-20-20230430","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007890-198212000-00007","article-title":"Late mortality and morbidity in recipients of long-term renal allografts.","volume":"34","author":"Kirkman","year":"1982","journal-title":"Transplantation"},{"key":"R20-20-20230430","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.transproceed.2009.01.025","article-title":"Composite tissue allotransplantation: A proposed classification system based on relative complexity.","volume":"41","author":"Gordon","year":"2009","journal-title":"Transplant Proc"},{"key":"R21-20-20230430","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/01.TP.0000161221.17627.8A","article-title":"Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation.","volume":"79","author":"Gruessner","year":"2005","journal-title":"Transplantation"},{"key":"R22-20-20230430","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa071074","article-title":"HLA-mismatched renal transplantation without maintenance immunosuppression.","volume":"358","author":"Kawai","year":"2008","journal-title":"N Engl J Med"},{"key":"R23-20-20230430","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/01.TP.0000142674.78268.01","article-title":"Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: With particular reference to hepatitis C virus.","volume":"78","author":"Marcos","year":"2004","journal-title":"Transplantation"},{"key":"R24-20-20230430","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/j.1600-6143.2008.02273.x","article-title":"Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: Results of a prospective randomized trial.","volume":"8","author":"Margreiter","year":"2008","journal-title":"Am J Transplant"},{"key":"R25-20-20230430","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa074191","article-title":"Tolerance and chimerism after renal and hematopoietic-cell transplantation.","volume":"358","author":"Scandling","year":"2008","journal-title":"N Engl J Med"},{"key":"R26-20-20230430","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1111\/j.1600-6143.2007.01987.x","article-title":"Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation.","volume":"7","author":"Shapiro","year":"2007","journal-title":"Am J Transplant"},{"key":"R27-20-20230430","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(03)13175-3","article-title":"Tolerogenic immunosuppression for organ transplantation.","volume":"361","author":"Starzl","year":"2003","journal-title":"Lancet"},{"key":"R28-20-20230430","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1111\/j.1600-6143.2006.01495.x","article-title":"Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy.","volume":"6","author":"Tan","year":"2006","journal-title":"Am J Transplant"},{"key":"R29-20-20230430","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/01.tp.0000250712.12389.3d","article-title":"Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes.","volume":"82","author":"Thai","year":"2006","journal-title":"Transplantation"},{"key":"R30-20-20230430","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.transproceed.2004.12.157","article-title":"The impact of Campath 1H induction in adult liver allotransplantation.","volume":"37","author":"Tryphonopoulos","year":"2005","journal-title":"Transplant Proc"},{"key":"R31-20-20230430","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1097\/01.TP.0000060250.50591.39","article-title":"Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation.","volume":"75","author":"Tzakis","year":"2003","journal-title":"Transplantation"},{"key":"R32-20-20230430","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/00007890-200212150-00022","article-title":"Lack of donor hyporesponsiveness and donor chimerism after clinical transplantation of the hand.","volume":"74","author":"Granger","year":"2002","journal-title":"Transplantation"},{"key":"R33-20-20230430","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1148\/radiology.188.3.8351334","article-title":"Hematopoietic bone marrow within the proximal humeral epiphysis in normal adults: Investigation with MR imaging.","volume":"188","author":"Mirowitz","year":"1993","journal-title":"Radiology"},{"key":"R34-20-20230430","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.jhsa.2007.06.013","article-title":"Immunologic approaches to composite tissue allograft.","volume":"32","author":"Taieb","year":"2007","journal-title":"J Hand Surg Am"},{"key":"R35-20-20230430","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(06)68935-6","article-title":"First human face allograft: Early report.","volume":"368","author":"Devauchelle","year":"2006","journal-title":"Lancet"},{"key":"R36-20-20230430","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/604712","article-title":"Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.","volume":"49","author":"Cuellar-Rodriguez","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R37-20-20230430","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.tp.0000180530.17683.02","article-title":"Cryptococcal Collaborative Transplant Study Group. Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome.","volume":"80","author":"Singh","year":"2005","journal-title":"Transplantation"},{"key":"R38-20-20230430","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1086\/375822","article-title":"Opportunistic mycelial fungal infections in organ transplant recipients: Emerging importance of non-Aspergillus mycelial fungi.","volume":"37","author":"Husain","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R39-20-20230430","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM200203143461121","article-title":"Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.","volume":"346","author":"Herrero","year":"2002","journal-title":"N Engl J Med"},{"key":"R41-20-20230430","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1128\/jcm.35.7.1706-1709.1997","article-title":"The first clinical isolate of Legionella parisiensis, from a liver transplant patient with pneumonia.","volume":"35","author":"Lo Presti","year":"1997","journal-title":"J Clin Microbiol"},{"key":"R42-20-20230430","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/BF01699244","article-title":"Fatal concomitant nosocomial Legionnaires disease and cytomegalovirus pneumonitis after cardiac transplantation.","volume":"22","author":"Harbarth","year":"1996","journal-title":"Intensive Care Med"},{"key":"R44-20-20230430","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/PRS.0b013e318208d03c","article-title":"Cytomegalovirus and other infectious issues related to face transplantation: Specific considerations, lessons learned, and future recommendations.","volume":"127","author":"Gordon","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"R45-20-20230430","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1056\/NEJMoa072828","article-title":"Outcomes 18 months after the first human partial face transplantation.","volume":"357","author":"Dubernard","year":"2007","journal-title":"N Engl J Med"},{"key":"R46-20-20230430","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(08)61276-3","article-title":"Human facial allotransplantation: A 2-year follow-up study.","volume":"372","author":"Guo","year":"2008","journal-title":"Lancet"},{"key":"R47-20-20230430","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/PRS.0b013e3181ec2089","article-title":"Procurement of total human face graft for allotransplantation: A preclinical study and the first clinical case.","volume":"126","author":"Meningaud","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"R49-20-20230430","first-page":"479","article-title":"Viral infections in transplant recipients.","volume":"100","author":"Razonable","year":"2009","journal-title":"Minerva Med"},{"key":"R51-20-20230430","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2174\/0929867003374778","article-title":"The impact of immunosuppressive drugs on the analysis of T cell activation.","volume":"7","author":"Rovira","year":"2000","journal-title":"Curr Med Chem"},{"key":"R52-20-20230430","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/j.transproceed.2011.06.031","article-title":"Insidious course of cytomegalovirus infection in hand transplant recipient: Case report, diagnostics, and treatment.","volume":"43","author":"Chelmonski","year":"2011","journal-title":"Transplant Proc"},{"key":"R53-20-20230430","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2006.00618.x","article-title":"Cytomegalovirus in transplantation: Challenging the status quo.","volume":"21","author":"Fishman","year":"2007","journal-title":"Clin Transplant"},{"key":"R54-20-20230430","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00007890-199503270-00008","article-title":"Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients.","volume":"59","author":"Grossi","year":"1995","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"R55-20-20230430","first-page":"7","article-title":"Advances in understanding cytomegalovirus infection after transplantation.","volume":"26","author":"Ho","year":"1994","journal-title":"Transplant Proc"},{"key":"R56-20-20230430","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7326\/0003-4819-144-5-200603070-00010","article-title":"Brief communication: Fatal human metapneumovirus infection in stem-cell transplant recipients.","volume":"144","author":"Englund","year":"2006","journal-title":"Ann Intern Med"},{"key":"R57-20-20230430","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-2007-976494","article-title":"Community respiratory virus infections in immunocompromised patients: Hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.","volume":"28","author":"Kim","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"R58-20-20230430","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00007890-197712000-00010","article-title":"Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients.","volume":"24","author":"Rubin","year":"1977","journal-title":"Transplantation"},{"key":"R59-20-20230430","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1001\/jama.1989.03420240121038","article-title":"The indirect effects of cytomegalovirus infection on the outcome of organ transplantation.","volume":"261","author":"Rubin","year":"1989","journal-title":"JAMA"},{"key":"R60-20-20230430","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.TP.0000146844.65273.62","article-title":"Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: Impact on viral load and late-onset cytomegalovirus disease.","volume":"79","author":"Singh","year":"2005","journal-title":"Transplantation"},{"key":"R61-20-20230430","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/rmv.513","article-title":"Antiviral drugs for cytomegalovirus in transplant recipients: Advantages of preemptive therapy.","volume":"16","author":"Singh","year":"2006","journal-title":"Rev Med Virol"},{"key":"R63-20-20230430","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(08)61277-5","article-title":"Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: A 1-year follow-up study.","volume":"372","author":"Lantieri","year":"2008","journal-title":"Lancet"},{"key":"R65-20-20230430","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01.tp.0000168454.68139.0a","article-title":"Cytomegalovirus-related complications in human hand transplantation.","volume":"80","author":"Schneeberger","year":"2005","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"R67-20-20230430","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1111\/j.1600-6143.2009.02900.x","article-title":"Herpes simplex virus infections in solid organ transplant recipients.","volume":"9","author":"Zuckerman","year":"2009","journal-title":"Am J Transplant"},{"key":"R68-20-20230430","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/clinids\/20.5.1346","article-title":"Pretransplantation assessment of the risk of lymphoproliferative disorder.","volume":"20","author":"Walker","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R69-20-20230430","first-page":"214","article-title":"Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.","volume":"14","author":"Walker","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"R70-20-20230430","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s11908-012-0296-y","article-title":"Emerging invasive fungal diseases in transplantation.","volume":"14","author":"Parize","year":"2012","journal-title":"Curr Infect Dis Rep"},{"key":"R71-20-20230430","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1086\/323463","article-title":"Coccidioidomycosis in solid organ transplantation.","volume":"33","author":"Blair","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R72-20-20230430","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archinte.1982.00340160069017","article-title":"Coccidioidomycosis in renal replacement therapy.","volume":"142","author":"Cohen","year":"1982","journal-title":"Arch Intern Med"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006534-201404000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T06:01:54Z","timestamp":1682834514000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006534-201404000-00020"}},"subtitle":["A Multicenter Perspective"],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000000015","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}